Cryptococcal pleuritis is rare in individuals with no underlying disease. We report a case of pulmonary cryptococcosis followed by pleuritis in a patient on fluconazole treatment. Biopsy of the pleura revealed a granuloma and a cryptococcal body, while PCR and sequence analysis of extracted DNA from the pleura proved the presence of Cryptococcus species, most likely C. neoformans. Voriconazole with flucytosine and drainage of the pleural effusion were effective in treating the patient.
Introduction
Cryptococcosis in humans is found worldwide. Cryptococcosis is rare in immunocompetent individuals and clinical manifestations of pulmonary infections are usually mild and asymptomatic [1] . Hence, cryptococcosis in immunocompromised hosts such as, human immunodeficiency virus (HIV) infected and acquired-immunodeficiency syndrome (AIDS) patients, becomes more severe and clinical manifestations become more diverse [2] .
Pulmonary inhalation of Cryptococcus neoformans is generally regarded as the initiator for diseases in humans and pulmonary cryptococcosis may present a wide variety of findings in chest X-ray films such as nodules, masses, pneumonia, and miliary lesions, however pleural disease is not common [3] . Although the frequency of cryptococcal pleuritis has increased recently because of an increasing number of immunocompromised patients [4, 5] , it is still rare among immunocompetent cryptococcosis patients.
We report here a rare case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment as maintenance therapy.
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Case report
A 24-year-old male patient who primarily lived in Nagasaki, Japan visited Nagasaki Municipal Hospital complaining of dry cough, right back pain and fever for 2 weeks.
He possessed no previous underlying diseases and no history of smoking or oral steroid use. He had visited Venice, Italy three months prior to the onset of his symptoms, where he had experienced a heavy exposure to pigeons, but had no history of breeding the birds. Chest X-ray films revealed infiltrative shadows with cavitation in the right lower lung field (Figure 1 ). Since serum cryptococcal antigen level was high (X 1,024), he was diagnosed as having pulmonary cryptococcosis and was referred to Nagasaki University Hospital for further treatment.
On admission, vital signs of the patient were as follows: body temperature: 36.5 ºC, heart rate: 76 beats/minute with a regular rhythm, respiratory rate: 14 breaths/minute and blood pressure: 111/65 mmHg. Physical examination revealed no rales or murmurs and no signs of systemic lymphadenopathy, hepatosplenomegaly, or pre-tibial edema.
There were no abnormalities on neurological examination such as neck stiffness or disorientation. Laboratory findings on admission were: white blood cells count: PCR analysis using extracted DNA from the pleura obtained under VATS was performed to identify the causative agent. Extraction of DNA from paraffin-embedded pleura was performed according to the method previously reported with minor modifications [6] . Briefly, five sections (thickness, 10 µm) of specimen cut by a sterile microtome blade were used. To remove paraffin wax, xylene was added, mixed, incubated at room temperature for 10 min, and centrifuged (at 15,000 rpm for 5 min).
The pellet was washed three times with ethanol, dried at room temperature and suspended in distilled water. Further extraction was performed by mechanical disruption by the glass bead technique as previously reported [7] . PCR was performed based on the protocol previously reported by Leaw et al. 
Discussion
Pleural diseases due to fungi are rare, with the reported frequency being about 1% of all pleural diseases [12] . Before the HIV/AIDS era, pleural effusions due to C. neoformans were extremely rare. However, recently, the frequency has reportedly increased to 5 to 25 % [4, 5] . More than half of the patients have moderate to severe underlying diseases such as AIDS, leukemia and lymphoma [13] , cryptococcal pleuritis being uncommon in patients without underlying diseases. Our patient, however, was a 24 year-old previously healthy man with no known predisposing conditions.
Another uncommon occurrence in our patient was that the pleural effusion gradually increased during treatment with L-AMB as well as with FLC. It is very rare for pleural effusion to increase during treatment in immunocompetent hosts. Direct extension of the primary pulmonary cryptococcal nodule into the pleural space causes pleural cryptococcosis [14] , with exudative effusions. Though laboratory findings demonstrated the exudative nature of the effusion in our case, eosinophils were elevated in the first aspirate. There are reports that eosinophils are increased in cryptococcal pleuritis [13, 15] , although the mechanism is not quite understood. The diagnosis of cryptococcal pleuritis requires proof of the presence of Cryptococcus spp. in the effusion or on pleural culture.
Since all attempts to culture sputum, BALF and pleural effusion failed in our patient, we performed PCR to detect fungal DNA extracted from the pleura obtained by VATS. Cryptococcus species, varieties and/or serotypes, by sequencing the entire ITS1-5.8S-ITS2 region [11] , or multiplex PCR of the laccase and capsule genes [16] .
However, our attempts to replicate these methodologies failed due to unknown reasons.
Although cryptococcal pleuritis sometimes resolves without medication especially in immunocompetent hosts [12] , drainage and administration of VRC and 5FC were required in our patient. A total of five months treatment of VRC and 5FC was effective, with no recurrence being observed after discontinuation of drug therapy. As
Cryptococcus was never isolated from sputum, BALF or pleural effusion, we were not able to perform drug susceptibility tests. It is possible that the strain that was 12 responsible for symptoms in our patient might have been resistant to older generations of azoles.
In conclusion, we experienced a rare case of cryptococcal pleuritis in an apparently immunocompetent host, who deteriorated during FLC treatment. Drainage of the pleural effusion and combination therapy of VRC and 5FC treatment were effective.
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